Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Ointments × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 4 Vascular Malformations 1 Uterine Cervical Dysplasia 1 Surgical Wound Infection 1 Pilonidal Sinus 1 Pancreatic Neoplasms 1 Pain 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 High-grade Anal Intraepithelial Neoplasia 1 Hemangioma, Capillary 1 Hemangioma 1 Head and Neck Neoplasms 1 Dermatitis, Contact 1 Condylomata Acuminata 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Cancer Lymphedema 1

Interventions

Cisplatin 203 Radiotherapy 150 Cetuximab 115 pembrolizumab 96 Fluorouracil 78 Docetaxel 76 Paclitaxel 66 Carboplatin 66 Radiotherapy, Intensity-Modulated 59 Nivolumab 33 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 Standard of Care 17 Cyclophosphamide 17 durvalumab 16 Surgical Procedures, Operative 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 15 Pemetrexed 15 atezolizumab 14 Bevacizumab 14 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Capecitabine 13 Amifostine 13 Radiosurgery 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01693159 2017-09-25

SUPPORT

National Center for Tumor Diseases, Heidelberg

Phase NA Unknown

Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡